Tests:Carcinoembryonic Antigen: Difference between revisions
- Department
- Biochemistry
Tests:Carcinoembryonic Antigen
No edit summary |
No edit summary |
||
| Line 26: | Line 26: | ||
|- | |- | ||
|Specimen Type | |Specimen Type | ||
| | |Serum | ||
Plasma | |||
|- | |- | ||
|Preferred | |Preferred | ||
| | |6 mL <span style="background:#e30022"> Red-Top </span> | ||
|- | |- | ||
|Acceptable | |Acceptable | ||
|6 mL<span style="background: #fbec5d"> Yellow-Top</span> | |||
|- | |||
|Specimen Transportation | |||
| | | | ||
|- | |- | ||
|Pediatric Requirements | |Pediatric Requirements | ||
|Minimum 0.5 mL blood in 6 mL <span style="background:#e30022"> | |Minimum 0.5 mL blood in 6 mL <span style="background:#e30022"> Red-Top </span> | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
| Line 44: | Line 45: | ||
|- | |- | ||
|Sample Type | |Sample Type | ||
| | |Serum | ||
Plasma | |||
|- | |- | ||
|Minimum Volume | |Minimum Volume | ||
| Line 62: | Line 64: | ||
|- | |- | ||
|Advanced Notice | |Advanced Notice | ||
|Not | |Not required | ||
|- | |- | ||
|Patient Preparation | |Patient Preparation | ||
|Not | |Not required | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
Revision as of 13:46, 31 January 2025
Overview | |
|---|---|
| Department | Biochemistry |
| Test Code | TCEA |
| Synonyms | CEA |
| Turnaround Time | 2 hours – 3 days |
| Stability – Add test | 24 hours |
Specimen Requirements | |
| Specimen Type | Serum
Plasma |
| Preferred | 6 mL Red-Top |
| Acceptable | 6 mL Yellow-Top |
| Specimen Transportation | |
| Pediatric Requirements | Minimum 0.5 mL blood in 6 mL Red-Top |
Aliquot Requirements | |
| Sample Type | Serum
Plasma |
| Minimum Volume | 100 uL |
| Aliquot Transportation | |
Clinical Information | |
| Reference Intervals | 0.0 - 5.0 ug/L |
| Test Method | Abbott Alinity Ci using Abbott reagents. |
| Advanced Notice | Not required |
| Patient Preparation | Not required |
Comments | |
| CEA is a marker for colorectal, gastrointestinal, lung and breast carcinomas.
CEA levels are not an absolute test for evidence of malignancy and must be used in conjunction with the clinical evaluation of the patient and other diagnostic evidence. Healthy non-smokers have CEA levels less than 3.0 µg/mL, while 6% of otherwise healthy smokers have CEA levels up to 5.0 µg/mL. CEA is not suitable as a screening test for the primary diagnosis of tumours. For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | |